🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today on BackTable: For #HCC, there are now multiple phase 3 studies on combination TACE & immunotherapy showing a significant benefit over TACE alone. How do these findings change the treatment algorithm? Drs. Richard Finn and Julius Chapiro explain. Listen now:

Great podcast with my colleague and friend Richard Finn UCLA Jonsson Comprehensive Cancer Center on #HCC #LiverCancer #TACE #Immunotherapy AASLD EASLnews ECIO SIO Society of Interventional Radiology Yale Cancer Center Smilow Cancer Hospital Yale IR

This HCC case study involves a large 10cm #HCC lesion and comorbid portal hypertension, which eliminates surgical resection as a treatment option. Our panel discusses the utility of locoregional therapy and potential downstaging for eventual liver transplant. Stream the entire

How does Y90 dosimetry change depending treatment intent and #HCC tumor location? Dr. Kirema Garcia-Reyes Kirema Garcia-Reyes, MD describes her strategy of selective embolization for multifocal lesions. Stream the full episode here: youtu.be/mtknCLeDAXY Enroll in our free

How can we utilize locoregional treatment sand immunotherapies in conjunction to treat HCC? Interventional radiologists and medical oncologists weigh into these decisions Enroll in our free BackTable+ course for CME credits: plus.backtable.com/courses/Multid… #ONC3 AstraZeneca

This discussion features a case of diffuse, bilobar #HCC lesions complicated by rupture. Our panel discusses locoregional and systemic therapy options. Stream the entire episode, with all case studies and imaging here: youtu.be/3DLVodvSGFU Enroll in our free BackTable+

#Y90 and #Immunotherapy are increasingly being used for a combination approach to treat unresectable #HCC-- In this panel discussion, we discuss optimal timing and dosing for this strategy. Enroll in our free BackTable+ course for CME credits: plus.backtable.com/courses/Multid… #ONC3

Drs. Zach Berman, Sid Padia, and Tyler Sandow walk us through an explanation of voxel-based dosimetry for Y90, including key definitions to know and the utility of dose-volume histograms. Stream the full episode here: youtu.be/mtknCLeDAXY Enroll in our free BackTable+

Season 2: Genitourinary Cancers-- We're kicking off with a multidisciplinary discussion about #TesticularCancer with Nabil Adra, Rich Matulewicz, and DrBagrodia.  Stream here: open.spotify.com/episode/36IFJ3… #ONC12 Indiana University Internal Medicine IU_UroOnc Clint Cary, MD MPH MBA Memorial Sloan Kettering Cancer Center Bernie Bochner, MD

In our final #HCC case study, we discuss a patient with adrenal metastases after liver transplant. Our panel contemplates different therapies, including tyrosine kinase inhibitors, cryoablation, and SBRT. Stream the entire episode, with all case studies and imaging here:

In Ep. 13, E Jason Abel, Dr. Louis Hinshaw, and Ruchika Talwar explain how urologists and radiologists work together to improve #kidneycancer treatment. #ONC13 UW Radiology UW Urology UW Urologic Oncology Vanderbilt Urology BackTable Vascular and Interventional ASCO open.spotify.com/episode/3GRagx…

How can pediatric and adult urologists team up to tackle complex cancer cases? Dr. Amanda Buchanan, Patrick Hensley, MD, Dr. Dave Rodeberg discuss interprofessional collaboration in urologic oncology. #ONC14 University of Kentucky Urology Residency Program Amanda Buchanan UK General Surgery Residency Program ASCO open.spotify.com/episode/4lwSEk…

What if the key to better cancer outcomes lies in mindfulness, movement, and diet? Viraj Master from Winship Cancer Institute of Emory University explains in-depth about integrative oncology and survivorship. #ONC15 #holistichealth Emory Urologic Oncology Emory Urology Bladder Cancer Advocacy Network ASCO open.spotify.com/episode/7Imk15…

In Ep. 16, nirm, Dr. Jeannie Hoffman-Censits, and Bogdana Schmidt MD, MPH discuss treatment for upper tract urothelial carcinoma (UTUC) using evidence-based medicine. #ONC16 Society of Urologic Oncology Huntsman Cancer Institute Johns Hopkins Medicine Johns Hopkins Kimmel Cancer Center UroToday.com ASCO open.spotify.com/episode/2yNQpS…

This week on BT Tumor Board: Episode 17 focuses on #penilecancer diagnosis and treatment, featuring #UroOnc Dr. Charles Peyton, #RadOnc Dr. Juanita Crook, and #MedOnc Dr. Andrea Apolo. #ONC17 Andrea Apolo, M.D. UAB Urology GSRGT Education Committee ASCO open.spotify.com/episode/688Njo…

🎉 We made the list! Our FREE CME on Combination Therapies for HCC just hit the Top 20 on myCME. Join thousands of peers advancing liver cancer care - and earn credit while you do it! ➡️ Enroll now: plus.backtable.com/courses/Multid… #CME #MedEd

This week on BT ONC: Ruchika Talwar and Kelly Bree discuss the various treatment options for intermediate-risk #NMIBC. #ONC18 #bladdercancer MD Anderson Cancer Center @UCSDUrology @VUMCUrology ASCO UroGen Pharma Ashish M. Kamat, MD, MBBS Tom Powles Shilpa Gupta Bladder Cancer Advocacy Network open.spotify.com/episode/1nat9E…